| 6.6 |
39.5 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 6.5 |
19.5 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 3.3 |
10.0 |
GO:1904298 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 3.2 |
71.2 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 3.2 |
25.6 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 2.8 |
11.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 2.8 |
8.3 |
GO:0051780 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 2.4 |
7.3 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 2.3 |
4.5 |
GO:0060557 |
positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 2.3 |
6.8 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 2.1 |
10.7 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 1.9 |
5.8 |
GO:0033242 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.9 |
7.7 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 1.9 |
5.7 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 1.9 |
3.7 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 1.7 |
5.0 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 1.6 |
9.7 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 1.6 |
4.8 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 1.6 |
1.6 |
GO:0010868 |
negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 1.5 |
6.1 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 1.5 |
4.5 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 1.5 |
9.0 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 1.5 |
4.4 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.5 |
1.5 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 1.4 |
12.8 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.4 |
5.5 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 1.4 |
6.8 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.3 |
4.0 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.3 |
4.0 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 1.3 |
6.6 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 1.3 |
3.9 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 1.3 |
5.1 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.3 |
5.1 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 1.3 |
3.8 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.2 |
9.9 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 1.2 |
4.8 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 1.2 |
1.2 |
GO:0032425 |
regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 1.2 |
5.9 |
GO:1902378 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 1.2 |
5.9 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) |
| 1.2 |
3.5 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.1 |
3.4 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.1 |
4.5 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 1.1 |
4.5 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 1.1 |
4.5 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.1 |
1.1 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 1.1 |
4.4 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 1.1 |
6.6 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 1.1 |
3.2 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 1.1 |
1.1 |
GO:0014015 |
positive regulation of gliogenesis(GO:0014015) |
| 1.1 |
1.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 1.0 |
5.2 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 1.0 |
3.1 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.0 |
3.0 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 1.0 |
1.0 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 1.0 |
4.0 |
GO:0031052 |
mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 1.0 |
3.0 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.0 |
2.0 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 1.0 |
3.8 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.0 |
5.7 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 1.0 |
1.0 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 1.0 |
1.0 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.9 |
4.7 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 0.9 |
2.8 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.9 |
4.7 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.9 |
2.7 |
GO:0014724 |
regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.9 |
0.9 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.9 |
2.7 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.9 |
2.6 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.9 |
5.3 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.9 |
2.6 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.9 |
4.4 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.9 |
6.1 |
GO:1902714 |
negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.9 |
0.9 |
GO:1901205 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.9 |
21.8 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.9 |
0.9 |
GO:0090307 |
mitotic spindle assembly(GO:0090307) |
| 0.9 |
6.0 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.9 |
3.4 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.9 |
3.4 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.8 |
2.5 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.8 |
3.3 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 |
2.5 |
GO:1902336 |
neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 0.8 |
4.9 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.8 |
2.5 |
GO:0036058 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.8 |
2.4 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.8 |
0.8 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.8 |
14.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.8 |
7.9 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.8 |
2.4 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) cysteine biosynthetic process via cystathionine(GO:0019343) |
| 0.8 |
0.8 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.8 |
2.3 |
GO:0032824 |
natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.8 |
6.2 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.8 |
6.2 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.8 |
2.3 |
GO:0052047 |
interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.8 |
6.9 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.8 |
2.3 |
GO:2000612 |
thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.8 |
2.3 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.8 |
0.8 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.8 |
3.0 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.8 |
2.3 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.7 |
5.9 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.7 |
2.2 |
GO:0043317 |
regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.7 |
1.4 |
GO:0060393 |
pathway-restricted SMAD protein phosphorylation(GO:0060389) regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
| 0.7 |
11.5 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.7 |
2.9 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.7 |
2.1 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.7 |
4.3 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.7 |
1.4 |
GO:0060397 |
JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.7 |
0.7 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.7 |
2.1 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.7 |
2.1 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.7 |
0.7 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.7 |
4.2 |
GO:0051216 |
cartilage development(GO:0051216) |
| 0.7 |
6.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.7 |
1.4 |
GO:0021623 |
oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.7 |
3.4 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.7 |
11.6 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.7 |
2.0 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 |
2.0 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.7 |
2.7 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.7 |
2.0 |
GO:0014876 |
response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.7 |
0.7 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.7 |
2.7 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.7 |
10.1 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.7 |
1.3 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.7 |
4.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.7 |
4.0 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.7 |
3.3 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.7 |
0.7 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.6 |
7.1 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.6 |
1.3 |
GO:2000309 |
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 0.6 |
4.5 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.6 |
5.1 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.6 |
1.9 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.6 |
5.7 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.6 |
2.6 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.6 |
2.6 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.6 |
3.2 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.6 |
1.3 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.6 |
2.5 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.6 |
0.6 |
GO:0002277 |
myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.6 |
1.9 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.6 |
3.8 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.6 |
2.5 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.6 |
1.9 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.6 |
0.6 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.6 |
1.9 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) peptidyl-glutamine modification(GO:0018199) isopeptide cross-linking(GO:0018262) |
| 0.6 |
3.1 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.6 |
4.3 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.6 |
17.8 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.6 |
1.8 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.6 |
5.5 |
GO:0046618 |
drug export(GO:0046618) |
| 0.6 |
1.8 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.6 |
1.8 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.6 |
0.6 |
GO:1900195 |
positive regulation of oocyte maturation(GO:1900195) |
| 0.6 |
2.4 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.6 |
4.2 |
GO:0051461 |
positive regulation of corticotropin secretion(GO:0051461) |
| 0.6 |
1.8 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.6 |
3.0 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.6 |
1.8 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.6 |
0.6 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.6 |
2.3 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.6 |
0.6 |
GO:2001020 |
regulation of response to DNA damage stimulus(GO:2001020) |
| 0.6 |
1.8 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.6 |
8.8 |
GO:0001660 |
fever generation(GO:0001660) |
| 0.6 |
0.6 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.6 |
2.3 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.6 |
0.6 |
GO:1903923 |
protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.6 |
2.3 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.6 |
0.6 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.6 |
1.7 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.6 |
1.1 |
GO:0051231 |
spindle elongation(GO:0051231) |
| 0.6 |
2.3 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.6 |
4.5 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.6 |
1.1 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.6 |
2.8 |
GO:0072679 |
thymocyte migration(GO:0072679) |
| 0.6 |
3.3 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.6 |
11.1 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.6 |
1.7 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.6 |
1.7 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.6 |
3.9 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.5 |
4.9 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.5 |
1.6 |
GO:1902869 |
regulation of amacrine cell differentiation(GO:1902869) |
| 0.5 |
2.7 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.5 |
0.5 |
GO:0045575 |
basophil activation(GO:0045575) |
| 0.5 |
9.2 |
GO:0001845 |
phagolysosome assembly(GO:0001845) |
| 0.5 |
0.5 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.5 |
2.7 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.5 |
2.2 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.5 |
4.3 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.5 |
3.2 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.5 |
1.6 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.5 |
4.8 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.5 |
0.5 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.5 |
2.6 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.5 |
2.1 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.5 |
1.6 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
| 0.5 |
4.7 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.5 |
2.1 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.5 |
3.1 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.5 |
0.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.5 |
5.2 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.5 |
1.0 |
GO:0007622 |
rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.5 |
1.0 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.5 |
6.6 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.5 |
3.0 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.5 |
1.5 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.5 |
1.5 |
GO:0097254 |
renal tubular secretion(GO:0097254) |
| 0.5 |
0.5 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.5 |
4.5 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.5 |
1.5 |
GO:0097069 |
cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.5 |
2.0 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.5 |
3.9 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.5 |
1.4 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.5 |
5.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.5 |
2.9 |
GO:1903977 |
positive regulation of glial cell migration(GO:1903977) |
| 0.5 |
8.1 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.5 |
0.5 |
GO:0002784 |
regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.5 |
4.2 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.5 |
0.9 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.5 |
6.5 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.5 |
1.9 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.5 |
0.5 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.5 |
1.9 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.5 |
7.8 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.5 |
6.4 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
9.2 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.5 |
0.5 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.5 |
3.6 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.5 |
0.5 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.5 |
2.7 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 |
1.8 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.5 |
1.8 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.5 |
2.3 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.5 |
0.5 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.5 |
4.5 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.5 |
0.5 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.4 |
1.8 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.4 |
2.7 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.4 |
0.9 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.4 |
2.2 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.4 |
6.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.4 |
1.3 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.4 |
0.9 |
GO:2000449 |
CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.4 |
2.2 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.4 |
7.0 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.4 |
0.4 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.4 |
1.3 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.4 |
1.7 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.4 |
1.3 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.4 |
0.4 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.4 |
0.9 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 0.4 |
3.9 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.4 |
3.5 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.4 |
1.3 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.4 |
2.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.4 |
2.2 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.4 |
0.9 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 |
1.3 |
GO:0021586 |
pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.4 |
0.9 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 0.4 |
5.1 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.4 |
4.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.4 |
1.3 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 |
3.0 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.4 |
0.4 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.4 |
3.4 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.4 |
5.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.4 |
1.2 |
GO:0061534 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.4 |
1.7 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.4 |
2.1 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.4 |
1.2 |
GO:0042321 |
negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
| 0.4 |
2.1 |
GO:0002543 |
activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.4 |
7.0 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.4 |
0.4 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.4 |
2.5 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.4 |
1.2 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.4 |
1.2 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.4 |
1.6 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.4 |
3.3 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.4 |
1.6 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.4 |
1.2 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 |
3.2 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.4 |
2.8 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.4 |
1.6 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
1.2 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.4 |
9.2 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.4 |
2.8 |
GO:0072025 |
distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.4 |
0.8 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.4 |
0.8 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.4 |
0.8 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.4 |
3.2 |
GO:0021683 |
cerebellar granular layer morphogenesis(GO:0021683) |
| 0.4 |
2.4 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 |
0.8 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.4 |
2.4 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.4 |
2.0 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.4 |
4.7 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.4 |
1.2 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.4 |
1.9 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.4 |
0.4 |
GO:0002761 |
regulation of myeloid leukocyte differentiation(GO:0002761) regulation of osteoclast differentiation(GO:0045670) |
| 0.4 |
10.0 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.4 |
0.8 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.4 |
0.8 |
GO:0031056 |
regulation of histone modification(GO:0031056) |
| 0.4 |
1.5 |
GO:0060426 |
lung vasculature development(GO:0060426) |
| 0.4 |
2.3 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.4 |
1.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
7.2 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.4 |
4.6 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.4 |
3.8 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.4 |
2.3 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.4 |
4.2 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.4 |
1.5 |
GO:0006808 |
regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
| 0.4 |
1.9 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.4 |
5.3 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.4 |
1.9 |
GO:1904744 |
regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.4 |
0.8 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.4 |
2.3 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.4 |
0.7 |
GO:0014034 |
neural crest cell fate commitment(GO:0014034) |
| 0.4 |
0.4 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.4 |
1.1 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
| 0.4 |
0.4 |
GO:0099638 |
endosome to plasma membrane protein transport(GO:0099638) |
| 0.4 |
1.5 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 |
1.5 |
GO:0042160 |
lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.4 |
4.4 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.4 |
0.4 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 |
1.5 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.4 |
2.2 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.4 |
2.2 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.4 |
0.4 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.4 |
0.4 |
GO:0071706 |
tumor necrosis factor superfamily cytokine production(GO:0071706) |
| 0.4 |
1.1 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.4 |
1.1 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.4 |
5.8 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.4 |
1.8 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.4 |
1.1 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.4 |
0.7 |
GO:0017145 |
stem cell division(GO:0017145) |
| 0.4 |
0.4 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 |
0.7 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 |
4.0 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.4 |
2.5 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 |
1.4 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.4 |
0.4 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.4 |
2.1 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.4 |
1.1 |
GO:0098759 |
response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.4 |
1.8 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 |
1.1 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.4 |
1.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 |
1.4 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.4 |
1.4 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 |
1.1 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.4 |
3.2 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.4 |
1.1 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.4 |
1.1 |
GO:2000687 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.4 |
7.0 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.4 |
40.2 |
GO:0070268 |
cornification(GO:0070268) |
| 0.4 |
0.7 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.4 |
0.4 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 0.3 |
1.7 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
0.3 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.3 |
1.7 |
GO:0070305 |
response to cGMP(GO:0070305) |
| 0.3 |
1.0 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.3 |
1.0 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.3 |
1.0 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.3 |
1.7 |
GO:1903243 |
negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.3 |
0.7 |
GO:2000547 |
myeloid dendritic cell chemotaxis(GO:0002408) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.3 |
0.7 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.3 |
3.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.3 |
1.0 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.3 |
3.7 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.3 |
2.4 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.3 |
0.3 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.3 |
0.7 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.3 |
0.7 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.3 |
1.3 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.3 |
1.0 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.3 |
0.7 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.3 |
1.0 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.3 |
1.0 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.3 |
3.7 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 |
0.7 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.3 |
2.3 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.3 |
0.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.3 |
1.0 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.3 |
0.7 |
GO:0030278 |
regulation of ossification(GO:0030278) |
| 0.3 |
0.7 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.3 |
1.0 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.3 |
0.7 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.3 |
1.0 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 |
3.6 |
GO:1905049 |
negative regulation of metallopeptidase activity(GO:1905049) |
| 0.3 |
0.3 |
GO:0003231 |
cardiac ventricle development(GO:0003231) |
| 0.3 |
1.0 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.3 |
1.0 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.3 |
3.3 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 |
0.3 |
GO:1904528 |
positive regulation of microtubule binding(GO:1904528) |
| 0.3 |
1.6 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.3 |
2.6 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.3 |
1.0 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.3 |
3.9 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.3 |
3.2 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 |
1.6 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.3 |
1.0 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.3 |
1.3 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.3 |
0.6 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.3 |
1.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.3 |
1.3 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 |
0.6 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.3 |
0.9 |
GO:0055013 |
cardiac muscle cell development(GO:0055013) |
| 0.3 |
0.9 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.3 |
0.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
0.9 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.3 |
1.3 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.3 |
4.7 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.3 |
0.3 |
GO:0009725 |
response to hormone(GO:0009725) |
| 0.3 |
3.7 |
GO:0060600 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.3 |
1.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.3 |
5.6 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.3 |
1.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.3 |
1.6 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.3 |
0.6 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.3 |
0.9 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.3 |
0.6 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.3 |
0.6 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.3 |
1.5 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.3 |
3.1 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.3 |
0.9 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.3 |
1.5 |
GO:0070980 |
biphenyl catabolic process(GO:0070980) |
| 0.3 |
0.6 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.3 |
4.3 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.3 |
0.3 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.3 |
1.5 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.3 |
0.9 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.3 |
1.2 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.3 |
5.2 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.3 |
0.6 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.3 |
4.2 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.3 |
5.7 |
GO:0006469 |
negative regulation of protein kinase activity(GO:0006469) |
| 0.3 |
0.9 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 |
1.5 |
GO:0010819 |
regulation of T cell chemotaxis(GO:0010819) |
| 0.3 |
0.6 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.3 |
0.9 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.3 |
0.3 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.3 |
0.6 |
GO:0033091 |
positive regulation of immature T cell proliferation(GO:0033091) |
| 0.3 |
0.9 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 |
2.7 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.3 |
1.2 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.3 |
3.6 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.3 |
6.2 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.3 |
1.5 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.3 |
2.1 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.3 |
0.3 |
GO:0043200 |
response to amino acid(GO:0043200) |
| 0.3 |
0.6 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.3 |
3.5 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.3 |
0.3 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 |
1.5 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.3 |
2.9 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.3 |
1.5 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.3 |
0.6 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.3 |
0.6 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 0.3 |
0.3 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.3 |
5.0 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.3 |
7.3 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
1.8 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.3 |
0.6 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.3 |
0.6 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.3 |
0.6 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.3 |
3.8 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 |
1.7 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
0.6 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.3 |
0.3 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.3 |
3.8 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
2.3 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 |
2.3 |
GO:1903760 |
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 0.3 |
0.3 |
GO:0007272 |
ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
| 0.3 |
1.4 |
GO:0003229 |
ventricular cardiac muscle tissue development(GO:0003229) |
| 0.3 |
0.9 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.3 |
0.3 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.3 |
0.9 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.3 |
1.1 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.3 |
0.6 |
GO:0005988 |
lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.3 |
3.4 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 |
0.3 |
GO:1903242 |
regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
| 0.3 |
1.1 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.3 |
0.6 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.3 |
2.2 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.3 |
1.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.3 |
0.8 |
GO:0050808 |
synapse organization(GO:0050808) |
| 0.3 |
1.7 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 |
3.4 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.3 |
0.6 |
GO:0030282 |
bone mineralization(GO:0030282) |
| 0.3 |
0.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.3 |
1.1 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.3 |
0.6 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.3 |
3.6 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 |
2.2 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.3 |
3.3 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.3 |
1.1 |
GO:0006565 |
L-serine catabolic process(GO:0006565) |
| 0.3 |
0.6 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.3 |
2.2 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.3 |
2.2 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.3 |
0.8 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.3 |
0.3 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.3 |
1.1 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
| 0.3 |
1.1 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.3 |
0.3 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.3 |
0.5 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.3 |
1.4 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.3 |
2.7 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.3 |
7.4 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.3 |
0.8 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.3 |
0.5 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.3 |
3.0 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.3 |
0.3 |
GO:0098868 |
bone growth(GO:0098868) |
| 0.3 |
0.8 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.3 |
2.2 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.3 |
0.5 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.3 |
4.1 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.3 |
0.5 |
GO:0015820 |
leucine transport(GO:0015820) |
| 0.3 |
0.3 |
GO:0051710 |
regulation of cytolysis in other organism(GO:0051710) |
| 0.3 |
0.5 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.3 |
1.3 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
13.7 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.3 |
0.5 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.3 |
0.8 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.3 |
1.6 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.3 |
0.3 |
GO:2000866 |
positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.3 |
1.1 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 |
0.5 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 |
0.3 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 |
1.6 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 |
1.6 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.3 |
0.3 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.3 |
1.0 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.3 |
4.2 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.3 |
2.1 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 |
5.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.3 |
1.3 |
GO:0009730 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.3 |
1.0 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.3 |
0.8 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 |
0.8 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.3 |
0.8 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.3 |
8.8 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 |
0.3 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) |
| 0.3 |
0.3 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.3 |
0.3 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 |
13.1 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.3 |
0.5 |
GO:1903533 |
regulation of protein targeting(GO:1903533) |
| 0.3 |
2.5 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.3 |
3.8 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
0.8 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.3 |
2.0 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.3 |
0.5 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.3 |
1.8 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.3 |
1.0 |
GO:0035564 |
regulation of kidney size(GO:0035564) |
| 0.3 |
0.3 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.3 |
0.5 |
GO:0034971 |
histone H3-R17 methylation(GO:0034971) |
| 0.3 |
6.5 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.3 |
1.3 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.3 |
1.0 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.2 |
0.2 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.2 |
0.5 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
1.7 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
3.2 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.2 |
0.7 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.2 |
1.0 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.2 |
2.5 |
GO:1903944 |
negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 |
1.0 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.2 |
0.7 |
GO:1904604 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) regulation of connective tissue replacement(GO:1905203) negative regulation of connective tissue replacement(GO:1905204) |
| 0.2 |
1.5 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.2 |
0.7 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 |
0.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.2 |
0.2 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.2 |
0.2 |
GO:0019448 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.2 |
2.5 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
0.7 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.2 |
0.2 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 |
1.5 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 |
1.9 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.2 |
0.5 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.2 |
0.7 |
GO:1904640 |
response to methionine(GO:1904640) |
| 0.2 |
1.5 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.2 |
0.2 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.2 |
1.0 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.2 |
1.0 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.2 |
7.5 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.2 |
0.2 |
GO:0035315 |
hair cell differentiation(GO:0035315) |
| 0.2 |
0.2 |
GO:0060931 |
sinoatrial node cell development(GO:0060931) |
| 0.2 |
1.4 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.2 |
0.2 |
GO:0070231 |
T cell apoptotic process(GO:0070231) |
| 0.2 |
0.7 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.2 |
0.5 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 |
0.5 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.2 |
1.2 |
GO:0048548 |
regulation of pinocytosis(GO:0048548) |
| 0.2 |
0.2 |
GO:1900084 |
regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 0.2 |
1.0 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.2 |
0.5 |
GO:0033260 |
nuclear DNA replication(GO:0033260) cell cycle DNA replication(GO:0044786) |
| 0.2 |
0.5 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 |
0.7 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
0.2 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.2 |
0.2 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.2 |
0.7 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
0.7 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 |
0.9 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
0.2 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.2 |
1.9 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.2 |
1.2 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.2 |
0.7 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.2 |
0.9 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.2 |
1.6 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 |
5.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 |
1.4 |
GO:0002774 |
Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.2 |
0.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
1.2 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 |
1.9 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
0.2 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) |
| 0.2 |
0.2 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.2 |
0.7 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.2 |
2.3 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.2 |
0.5 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.2 |
1.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.2 |
0.9 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 |
0.5 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.2 |
1.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 |
0.9 |
GO:0001808 |
negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.2 |
1.4 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.2 |
7.0 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.2 |
0.2 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.2 |
0.5 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.2 |
0.9 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.2 |
0.2 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
0.2 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 |
0.7 |
GO:0038124 |
toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.2 |
0.9 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.2 |
1.3 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.2 |
0.2 |
GO:1904938 |
dopaminergic neuron axon guidance(GO:0036514) serotonergic neuron axon guidance(GO:0036515) planar cell polarity pathway involved in axon guidance(GO:1904938) |
| 0.2 |
0.4 |
GO:2000295 |
regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.2 |
0.4 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.2 |
0.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.2 |
0.7 |
GO:0051125 |
regulation of actin nucleation(GO:0051125) |
| 0.2 |
0.4 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.2 |
2.4 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 |
1.3 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.2 |
0.7 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.2 |
0.7 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 |
0.9 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.2 |
0.7 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.2 |
0.9 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.2 |
2.9 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 |
0.4 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 0.2 |
1.1 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.2 |
0.4 |
GO:0003342 |
proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.2 |
0.7 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.2 |
0.7 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 |
3.7 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 |
1.3 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.2 |
0.7 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.2 |
2.4 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 |
1.1 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 |
0.2 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.2 |
0.6 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 |
0.9 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.2 |
0.6 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 0.2 |
0.2 |
GO:0072678 |
T cell migration(GO:0072678) |
| 0.2 |
0.6 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.2 |
0.4 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 |
0.6 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.2 |
1.1 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 |
1.5 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
0.8 |
GO:0009407 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.2 |
0.2 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.2 |
0.8 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.2 |
1.5 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 |
3.2 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.2 |
0.8 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 |
0.6 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.2 |
0.8 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
1.7 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.2 |
0.4 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 0.2 |
0.4 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.2 |
1.5 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.2 |
2.5 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.2 |
0.6 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.2 |
1.0 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
2.1 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.2 |
0.2 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.2 |
1.0 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 |
2.1 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 |
0.4 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
6.6 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.2 |
0.2 |
GO:0002042 |
cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.2 |
0.8 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 |
0.6 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.2 |
0.8 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.2 |
0.4 |
GO:1902567 |
negative regulation of eosinophil activation(GO:1902567) negative regulation of membrane invagination(GO:1905154) negative regulation of eosinophil migration(GO:2000417) |
| 0.2 |
0.4 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.2 |
1.0 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 |
0.8 |
GO:0010919 |
regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.2 |
0.6 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.2 |
0.6 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.2 |
2.0 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 |
0.8 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.2 |
0.2 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 |
1.0 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.2 |
0.2 |
GO:0040020 |
regulation of meiotic nuclear division(GO:0040020) |
| 0.2 |
0.6 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.2 |
3.6 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.2 |
2.4 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.2 |
1.2 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.2 |
0.2 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.2 |
0.8 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.2 |
1.4 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
0.8 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.2 |
2.0 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
1.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.2 |
0.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
0.4 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 |
0.6 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.2 |
1.0 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.2 |
0.4 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.2 |
0.6 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.2 |
0.2 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
1.2 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.2 |
13.0 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.2 |
0.2 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.2 |
0.4 |
GO:0016045 |
detection of bacterium(GO:0016045) |
| 0.2 |
1.0 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 |
0.8 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
0.4 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.2 |
0.6 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.2 |
1.0 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 |
0.2 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 |
0.6 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.2 |
1.3 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.2 |
0.8 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.2 |
0.4 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.2 |
0.2 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 |
0.6 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.2 |
1.1 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
0.4 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.2 |
0.4 |
GO:0070458 |
cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 |
0.2 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.2 |
0.4 |
GO:0044107 |
cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
| 0.2 |
0.9 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.2 |
1.7 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 |
4.5 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 |
0.4 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.2 |
0.6 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.2 |
0.4 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 |
1.8 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
1.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
3.9 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.2 |
0.9 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
0.7 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.2 |
3.3 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.2 |
0.4 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.2 |
1.8 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
6.2 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.2 |
6.0 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 |
2.7 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
1.1 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 |
0.9 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 |
0.9 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.2 |
2.9 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.2 |
0.4 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.2 |
1.3 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
0.4 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.2 |
4.9 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.2 |
0.9 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.2 |
0.4 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.2 |
2.9 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.2 |
0.2 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.2 |
2.1 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.2 |
1.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.2 |
1.1 |
GO:0030421 |
defecation(GO:0030421) |
| 0.2 |
0.2 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 |
0.5 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 |
0.4 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.2 |
0.5 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.2 |
0.7 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.2 |
0.2 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.2 |
0.4 |
GO:0042700 |
luteinizing hormone signaling pathway(GO:0042700) |
| 0.2 |
3.3 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 |
0.5 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.2 |
0.9 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.2 |
0.9 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 |
0.3 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.2 |
0.5 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.2 |
2.1 |
GO:0051412 |
response to corticosterone(GO:0051412) |
| 0.2 |
0.3 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.2 |
0.3 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
1.4 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.2 |
0.3 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.2 |
0.7 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.2 |
0.5 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.2 |
0.9 |
GO:0021615 |
glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.2 |
0.9 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.2 |
0.5 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 |
0.2 |
GO:1990869 |
response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.2 |
0.5 |
GO:0001207 |
histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.2 |
0.5 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.2 |
0.3 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.2 |
1.4 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.2 |
1.2 |
GO:0042635 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.2 |
0.2 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.2 |
0.7 |
GO:0042853 |
L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.2 |
0.5 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.2 |
0.2 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.2 |
0.5 |
GO:0070352 |
positive regulation of white fat cell proliferation(GO:0070352) |
| 0.2 |
1.5 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 |
0.2 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.2 |
0.5 |
GO:0018194 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 |
0.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.2 |
0.5 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 |
0.7 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.2 |
1.5 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.2 |
0.7 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
1.0 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
0.5 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 |
0.5 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.2 |
0.3 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
0.3 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.2 |
0.5 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.2 |
0.8 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.2 |
0.5 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.2 |
0.2 |
GO:0055069 |
zinc ion homeostasis(GO:0055069) |
| 0.2 |
0.2 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.2 |
0.5 |
GO:0051934 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.2 |
1.0 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.2 |
0.2 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.2 |
0.2 |
GO:0071287 |
cellular response to manganese ion(GO:0071287) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.2 |
0.8 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 |
0.7 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 |
0.2 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 |
0.2 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 |
1.1 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.2 |
1.0 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.2 |
0.3 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.2 |
1.1 |
GO:0007249 |
I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
| 0.2 |
0.8 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.2 |
0.6 |
GO:0010829 |
negative regulation of glucose transport(GO:0010829) |
| 0.2 |
1.5 |
GO:0006366 |
transcription from RNA polymerase II promoter(GO:0006366) |
| 0.2 |
2.9 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
0.6 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 |
0.8 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.2 |
0.3 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.2 |
0.6 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.2 |
1.4 |
GO:0008356 |
asymmetric cell division(GO:0008356) |
| 0.2 |
0.3 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.2 |
6.2 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
0.8 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
1.3 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.2 |
1.0 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.2 |
2.5 |
GO:0016048 |
detection of temperature stimulus(GO:0016048) |
| 0.2 |
1.1 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.2 |
1.1 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.2 |
0.2 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
0.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
0.3 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.2 |
2.1 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.2 |
1.7 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.2 |
1.9 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 |
0.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
0.6 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 |
0.3 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.2 |
0.3 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.2 |
1.7 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 |
3.3 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.2 |
0.2 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.2 |
0.6 |
GO:0009253 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.2 |
1.7 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.2 |
1.2 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.2 |
1.7 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.2 |
0.5 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.2 |
1.8 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
0.5 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 0.2 |
1.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 |
0.3 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
0.3 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
1.7 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.2 |
7.4 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 |
0.6 |
GO:0007219 |
Notch signaling pathway(GO:0007219) |
| 0.2 |
0.5 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.2 |
0.6 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 |
0.9 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
0.5 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 |
0.5 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.1 |
0.7 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.4 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 |
0.4 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 |
0.6 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
0.6 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
1.0 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 |
0.3 |
GO:0071362 |
cellular response to ether(GO:0071362) |
| 0.1 |
1.2 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.1 |
0.1 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
0.3 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
1.0 |
GO:0060872 |
semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
| 0.1 |
0.3 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.3 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 |
0.6 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
0.1 |
GO:0048143 |
astrocyte activation(GO:0048143) |
| 0.1 |
0.7 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.1 |
0.9 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.3 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
0.1 |
GO:1902668 |
negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.1 |
0.7 |
GO:1900116 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.1 |
0.1 |
GO:0046440 |
L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.1 |
0.4 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 0.1 |
0.1 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.1 |
0.9 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.3 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
0.7 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.1 |
0.6 |
GO:0021855 |
hypothalamus cell migration(GO:0021855) |
| 0.1 |
0.4 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.1 |
0.9 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.4 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.4 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
5.9 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.6 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
| 0.1 |
0.4 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.1 |
0.9 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 |
1.0 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.7 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 |
0.7 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 |
0.8 |
GO:0009972 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 |
0.8 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.1 |
1.0 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.4 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
0.4 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
| 0.1 |
0.3 |
GO:1990036 |
positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 0.1 |
0.7 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.4 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.1 |
0.3 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 |
0.3 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.1 |
0.7 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.1 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.4 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 |
1.7 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 |
0.1 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.1 |
0.5 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.1 |
0.8 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.7 |
GO:0019556 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 |
2.0 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.1 |
0.3 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.1 |
0.3 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.1 |
1.4 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.4 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.4 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.1 |
0.5 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.1 |
0.8 |
GO:0065002 |
intracellular protein transmembrane transport(GO:0065002) |
| 0.1 |
0.7 |
GO:0002374 |
cytokine secretion involved in immune response(GO:0002374) |
| 0.1 |
3.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.1 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.1 |
2.3 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.5 |
GO:0048483 |
autonomic nervous system development(GO:0048483) |
| 0.1 |
0.3 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 |
0.5 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.1 |
0.9 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
0.8 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.4 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
0.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.5 |
GO:0043302 |
positive regulation of leukocyte degranulation(GO:0043302) |
| 0.1 |
0.3 |
GO:0002337 |
B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
| 0.1 |
0.3 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
0.4 |
GO:0032459 |
regulation of protein oligomerization(GO:0032459) |
| 0.1 |
0.4 |
GO:0019085 |
early viral transcription(GO:0019085) late viral transcription(GO:0019086) |
| 0.1 |
0.4 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 |
4.2 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
2.4 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
0.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.9 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.5 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
1.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.1 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 |
0.5 |
GO:0002483 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
| 0.1 |
0.3 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 |
0.3 |
GO:0048021 |
regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
| 0.1 |
0.4 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
3.4 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 |
0.8 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 |
0.4 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.1 |
1.4 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.1 |
0.4 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 |
0.1 |
GO:0055008 |
cardiac muscle tissue morphogenesis(GO:0055008) |
| 0.1 |
1.2 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 |
0.4 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
0.3 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.5 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.1 |
0.4 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
7.3 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
2.7 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
0.9 |
GO:0044062 |
regulation of excretion(GO:0044062) |
| 0.1 |
0.5 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
0.5 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.1 |
0.8 |
GO:0010888 |
negative regulation of lipid storage(GO:0010888) |
| 0.1 |
0.9 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
0.3 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 |
0.9 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 |
0.5 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.1 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
1.5 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 |
1.4 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 |
0.3 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
0.1 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
0.9 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.1 |
0.5 |
GO:2001106 |
regulation of guanyl-nucleotide exchange factor activity(GO:1905097) regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.5 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.1 |
0.1 |
GO:0071352 |
cellular response to interleukin-2(GO:0071352) |
| 0.1 |
0.4 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 |
0.2 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 |
0.4 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.1 |
0.5 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.4 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.1 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 |
1.0 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.1 |
0.2 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.1 |
0.9 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 |
0.7 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.1 |
0.4 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.1 |
2.6 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.9 |
GO:0015840 |
urea transport(GO:0015840) |
| 0.1 |
2.8 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.5 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.6 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.1 |
0.4 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
1.8 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 |
2.1 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.2 |
GO:0072126 |
positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
| 0.1 |
1.7 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.2 |
GO:0051659 |
maintenance of mitochondrion location(GO:0051659) |
| 0.1 |
0.8 |
GO:0051597 |
response to methylmercury(GO:0051597) |
| 0.1 |
0.8 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
0.4 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.1 |
5.5 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.1 |
0.5 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.1 |
4.2 |
GO:0006939 |
smooth muscle contraction(GO:0006939) |
| 0.1 |
0.4 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.1 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.1 |
1.2 |
GO:0097106 |
postsynaptic density organization(GO:0097106) |
| 0.1 |
0.6 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 |
0.8 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.1 |
0.9 |
GO:0046078 |
pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.1 |
4.3 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.1 |
0.5 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.1 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.1 |
0.1 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.1 |
0.2 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
0.2 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 |
0.2 |
GO:0036294 |
cellular response to decreased oxygen levels(GO:0036294) |
| 0.1 |
0.2 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.1 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.7 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
0.2 |
GO:0045900 |
cytoplasmic translational elongation(GO:0002182) negative regulation of translational elongation(GO:0045900) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 |
0.3 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
0.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.1 |
0.6 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.5 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
0.8 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 |
0.7 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.1 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 |
0.1 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
| 0.1 |
0.5 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.7 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.3 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.1 |
0.5 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
0.2 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.2 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
1.8 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.8 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.6 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
0.2 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
2.9 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.1 |
0.7 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.1 |
0.4 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.1 |
1.5 |
GO:0051294 |
establishment of spindle orientation(GO:0051294) |
| 0.1 |
0.3 |
GO:0051957 |
positive regulation of amino acid transport(GO:0051957) |
| 0.1 |
0.1 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 0.1 |
0.9 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.6 |
GO:0042749 |
regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.1 |
0.1 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) |
| 0.1 |
0.9 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.1 |
0.3 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 |
0.1 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.1 |
GO:0042363 |
fat-soluble vitamin catabolic process(GO:0042363) |
| 0.1 |
0.4 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 |
5.1 |
GO:0006026 |
aminoglycan catabolic process(GO:0006026) |
| 0.1 |
0.3 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 |
0.8 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
1.6 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.1 |
0.2 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
1.2 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.4 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
0.1 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.1 |
0.1 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 |
0.1 |
GO:0021612 |
facial nerve structural organization(GO:0021612) |
| 0.1 |
1.2 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.3 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 |
0.5 |
GO:0045764 |
positive regulation of cellular amino acid metabolic process(GO:0045764) |
| 0.1 |
0.1 |
GO:0006522 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.1 |
7.5 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 |
0.2 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.1 |
16.0 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.3 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 |
0.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.3 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.1 |
0.7 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
1.1 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 |
8.6 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.2 |
GO:0045634 |
regulation of melanocyte differentiation(GO:0045634) |
| 0.1 |
0.3 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
2.9 |
GO:1903959 |
regulation of anion transmembrane transport(GO:1903959) |
| 0.1 |
2.8 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.2 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.6 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.3 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 |
0.1 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.1 |
1.0 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.8 |
GO:0052696 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.1 |
0.4 |
GO:0006979 |
response to oxidative stress(GO:0006979) |
| 0.1 |
0.7 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.1 |
0.3 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.1 |
0.8 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 |
0.9 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
0.2 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.1 |
0.3 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.1 |
0.1 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 |
0.4 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.3 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.1 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.1 |
0.8 |
GO:0001503 |
ossification(GO:0001503) |
| 0.1 |
2.2 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.1 |
0.2 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 |
1.0 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.1 |
0.2 |
GO:0008050 |
courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.2 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 |
0.1 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
| 0.1 |
0.9 |
GO:0043382 |
positive regulation of memory T cell differentiation(GO:0043382) |
| 0.1 |
0.6 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.2 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.3 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.3 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.1 |
0.6 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.1 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.4 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.1 |
0.5 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.2 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 0.1 |
0.4 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
3.3 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 |
0.1 |
GO:1902652 |
secondary alcohol metabolic process(GO:1902652) |
| 0.1 |
0.4 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
2.1 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.1 |
1.6 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.1 |
0.2 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 |
0.3 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.1 |
1.3 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.1 |
0.9 |
GO:0071415 |
cellular response to purine-containing compound(GO:0071415) |
| 0.1 |
1.9 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
0.4 |
GO:0007070 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.1 |
0.6 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.2 |
GO:0048867 |
ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.1 |
0.2 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.6 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.8 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.6 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
1.0 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.1 |
1.0 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
2.5 |
GO:0009584 |
detection of visible light(GO:0009584) |
| 0.1 |
3.3 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.1 |
0.7 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.2 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 |
5.8 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.1 |
0.4 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 |
0.1 |
GO:0001508 |
action potential(GO:0001508) |
| 0.1 |
0.7 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.1 |
3.6 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 |
0.3 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.1 |
GO:0036490 |
regulation of translation in response to endoplasmic reticulum stress(GO:0036490) |
| 0.1 |
0.6 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 0.1 |
0.2 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.1 |
0.5 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.1 |
GO:0014717 |
regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.1 |
0.4 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.1 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 |
0.3 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
0.1 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.1 |
0.3 |
GO:0051917 |
regulation of fibrinolysis(GO:0051917) |
| 0.1 |
0.5 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.4 |
GO:0010816 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
0.4 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
0.2 |
GO:0019856 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 |
3.1 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
1.0 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.1 |
0.4 |
GO:0048243 |
norepinephrine secretion(GO:0048243) |
| 0.1 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.2 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.1 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.1 |
0.2 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 |
1.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.2 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.1 |
4.3 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 |
0.3 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
0.3 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 |
0.4 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.7 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 |
0.2 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
| 0.1 |
0.2 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.1 |
0.1 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.1 |
1.6 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
1.7 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
0.3 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
1.1 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.4 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.1 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.1 |
0.9 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.4 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.1 |
0.8 |
GO:0009120 |
deoxyribonucleoside metabolic process(GO:0009120) |
| 0.1 |
0.3 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.7 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.1 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.1 |
0.3 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.1 |
0.9 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.1 |
0.3 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
1.1 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.1 |
0.4 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.1 |
0.6 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.6 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.8 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.1 |
0.3 |
GO:0007034 |
vacuolar transport(GO:0007034) |
| 0.1 |
0.1 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.1 |
0.7 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.5 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 |
0.1 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.1 |
0.7 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.2 |
GO:0002775 |
antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.1 |
0.6 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 |
0.2 |
GO:0090158 |
endoplasmic reticulum membrane organization(GO:0090158) |
| 0.1 |
0.3 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.5 |
GO:0032350 |
regulation of hormone metabolic process(GO:0032350) |
| 0.1 |
1.0 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.1 |
0.3 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.1 |
1.5 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.1 |
0.7 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.5 |
GO:0060546 |
negative regulation of necroptotic process(GO:0060546) |
| 0.1 |
0.9 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.4 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.1 |
2.8 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.4 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.2 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.1 |
0.6 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.3 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.2 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 |
1.2 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
0.1 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
1.0 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.1 |
3.6 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.4 |
GO:0033483 |
gas homeostasis(GO:0033483) |
| 0.1 |
0.8 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) |
| 0.1 |
0.5 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.1 |
0.8 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.1 |
0.2 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
5.2 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.2 |
GO:0001946 |
lymphangiogenesis(GO:0001946) |
| 0.1 |
0.3 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.1 |
1.2 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
0.4 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.6 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.1 |
0.4 |
GO:0045144 |
meiotic sister chromatid segregation(GO:0045144) |
| 0.1 |
0.1 |
GO:0001756 |
somitogenesis(GO:0001756) |
| 0.1 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.8 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.2 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.1 |
2.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.1 |
0.4 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.2 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.1 |
0.4 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.1 |
0.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.3 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.1 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
0.1 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.6 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
0.3 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
1.5 |
GO:0060674 |
placenta blood vessel development(GO:0060674) |
| 0.1 |
0.3 |
GO:0070344 |
fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
| 0.1 |
0.4 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 |
1.5 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.7 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.7 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.4 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
0.7 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 |
0.1 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 |
0.1 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 |
0.3 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.6 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 |
0.1 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 |
0.5 |
GO:0071371 |
cellular response to gonadotropin stimulus(GO:0071371) |
| 0.1 |
0.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.1 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 |
0.5 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
0.1 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.1 |
0.3 |
GO:0044065 |
regulation of respiratory system process(GO:0044065) |
| 0.1 |
0.3 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.1 |
0.1 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 |
0.6 |
GO:1990090 |
cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 |
1.3 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 |
0.5 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.1 |
0.4 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.5 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.1 |
0.1 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
0.6 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.1 |
0.7 |
GO:0019081 |
viral translation(GO:0019081) |
| 0.1 |
0.1 |
GO:0031577 |
spindle checkpoint(GO:0031577) |
| 0.1 |
2.0 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.8 |
GO:1902592 |
viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 |
2.3 |
GO:0042267 |
natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 |
1.3 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 |
0.5 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
0.5 |
GO:0031274 |
pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.5 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.1 |
0.2 |
GO:0060828 |
regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.1 |
0.3 |
GO:0044829 |
modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.9 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
1.1 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.1 |
0.1 |
GO:0002323 |
natural killer cell activation involved in immune response(GO:0002323) |
| 0.1 |
4.2 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 |
0.5 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.1 |
1.0 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
0.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.3 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 |
0.3 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.3 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 |
0.7 |
GO:0006853 |
carnitine shuttle(GO:0006853) |
| 0.1 |
0.4 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.1 |
0.1 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.1 |
0.3 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
0.1 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
0.3 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.8 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.1 |
0.1 |
GO:0070585 |
protein localization to mitochondrion(GO:0070585) |
| 0.1 |
0.5 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.1 |
GO:1901991 |
negative regulation of mitotic cell cycle phase transition(GO:1901991) |
| 0.1 |
0.1 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.1 |
0.2 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.1 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
0.2 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 |
0.1 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 |
0.1 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
0.2 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.1 |
0.1 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.1 |
0.1 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.1 |
2.1 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.3 |
GO:0006612 |
protein targeting to membrane(GO:0006612) |
| 0.1 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.1 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.1 |
0.4 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.6 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.1 |
0.9 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.5 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.1 |
0.1 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.1 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.1 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.1 |
0.3 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.1 |
0.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 |
0.2 |
GO:0019079 |
viral genome replication(GO:0019079) |
| 0.1 |
0.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.1 |
GO:0060926 |
cardiac pacemaker cell development(GO:0060926) |
| 0.1 |
0.3 |
GO:0030431 |
sleep(GO:0030431) |
| 0.1 |
0.4 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.9 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.1 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 |
0.2 |
GO:0061357 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 |
0.8 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
0.3 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 |
1.2 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.1 |
0.1 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.1 |
0.4 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.1 |
0.1 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) |
| 0.1 |
0.2 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.1 |
0.1 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 |
0.2 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.3 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.1 |
GO:1903660 |
negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.1 |
0.3 |
GO:0051645 |
Golgi localization(GO:0051645) |
| 0.1 |
0.1 |
GO:0052199 |
negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.1 |
0.1 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
0.2 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.1 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.1 |
0.1 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.9 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.1 |
0.1 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.1 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.2 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
0.3 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 |
0.4 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.9 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.1 |
0.6 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.0 |
0.5 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.0 |
0.3 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.0 |
0.0 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 |
0.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.5 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.0 |
0.0 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.0 |
0.0 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.0 |
0.3 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.2 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.2 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.1 |
GO:0032641 |
lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.0 |
0.0 |
GO:0021548 |
pons development(GO:0021548) |
| 0.0 |
0.2 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.0 |
0.7 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.0 |
0.2 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 |
0.6 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.1 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.0 |
0.1 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.0 |
0.3 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.2 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 |
1.1 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 |
1.1 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.1 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.0 |
0.2 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
0.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.4 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.1 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
0.2 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.0 |
0.2 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.0 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 |
0.5 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.2 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.0 |
0.3 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.0 |
0.2 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.0 |
0.2 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.2 |
GO:0046794 |
transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) |
| 0.0 |
0.1 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.0 |
0.2 |
GO:0010885 |
regulation of cholesterol storage(GO:0010885) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.2 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.0 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.0 |
0.1 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 |
0.0 |
GO:0015801 |
aromatic amino acid transport(GO:0015801) |
| 0.0 |
0.3 |
GO:0042438 |
melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.0 |
GO:0001768 |
establishment of T cell polarity(GO:0001768) |
| 0.0 |
0.2 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.2 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.0 |
1.8 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.3 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.2 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.0 |
0.6 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.2 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.0 |
2.3 |
GO:0051983 |
regulation of chromosome segregation(GO:0051983) |
| 0.0 |
0.2 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.0 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.3 |
GO:0042743 |
hydrogen peroxide metabolic process(GO:0042743) |
| 0.0 |
0.3 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) strand invasion(GO:0042148) |
| 0.0 |
0.0 |
GO:0003064 |
regulation of heart rate by hormone(GO:0003064) |
| 0.0 |
0.2 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.2 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 0.0 |
0.1 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.0 |
0.2 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.0 |
0.0 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.0 |
0.0 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.0 |
0.5 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 |
0.2 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 |
0.6 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 0.0 |
0.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.2 |
GO:0010907 |
positive regulation of glucose metabolic process(GO:0010907) |
| 0.0 |
0.2 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.3 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.1 |
GO:0051608 |
histamine transport(GO:0051608) |
| 0.0 |
0.3 |
GO:0032205 |
negative regulation of telomere maintenance(GO:0032205) negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 |
0.5 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.1 |
GO:0038188 |
cholecystokinin signaling pathway(GO:0038188) |
| 0.0 |
0.1 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.0 |
0.9 |
GO:0051209 |
release of sequestered calcium ion into cytosol(GO:0051209) negative regulation of sequestering of calcium ion(GO:0051283) |
| 0.0 |
0.1 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.0 |
0.1 |
GO:0090656 |
t-circle formation(GO:0090656) |
| 0.0 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
1.4 |
GO:2000117 |
negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 |
1.4 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.1 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) |
| 0.0 |
0.8 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.0 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.0 |
0.0 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.4 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.1 |
GO:0042723 |
thiamine-containing compound metabolic process(GO:0042723) |
| 0.0 |
0.1 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.0 |
0.3 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.0 |
0.2 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.0 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.2 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
0.2 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.0 |
0.1 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
1.4 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
0.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
0.1 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.0 |
0.0 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.0 |
1.5 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.2 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.2 |
GO:0032196 |
transposition(GO:0032196) |
| 0.0 |
0.6 |
GO:0010629 |
negative regulation of gene expression(GO:0010629) |
| 0.0 |
0.0 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 |
2.0 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.0 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.3 |
GO:0044036 |
cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.2 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.0 |
0.4 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.0 |
0.2 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.0 |
0.2 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.1 |
GO:0001971 |
negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.0 |
0.5 |
GO:0070423 |
nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.0 |
0.8 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 |
1.3 |
GO:0006096 |
glycolytic process(GO:0006096) |
| 0.0 |
1.0 |
GO:0007204 |
positive regulation of cytosolic calcium ion concentration(GO:0007204) |
| 0.0 |
0.2 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.0 |
0.4 |
GO:0003298 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.4 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.0 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.0 |
0.0 |
GO:0044179 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.0 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.4 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.2 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.0 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.0 |
0.4 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0015824 |
proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.0 |
0.1 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.1 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.7 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.2 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.0 |
0.4 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 |
0.0 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.2 |
GO:0050711 |
negative regulation of interleukin-1 secretion(GO:0050711) |
| 0.0 |
0.1 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 |
0.1 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
| 0.0 |
0.0 |
GO:0002664 |
regulation of T cell tolerance induction(GO:0002664) |
| 0.0 |
0.1 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.0 |
0.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.0 |
0.0 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.0 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.0 |
1.5 |
GO:0050770 |
regulation of axonogenesis(GO:0050770) |
| 0.0 |
0.0 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 |
0.1 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 |
0.0 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 |
0.1 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
| 0.0 |
0.0 |
GO:0001952 |
regulation of cell-matrix adhesion(GO:0001952) |
| 0.0 |
0.0 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 |
0.0 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.0 |
0.1 |
GO:0030100 |
regulation of endocytosis(GO:0030100) |
| 0.0 |
0.0 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.0 |
0.6 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.0 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.0 |
0.1 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.0 |
0.1 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.0 |
0.1 |
GO:0009112 |
nucleobase metabolic process(GO:0009112) |
| 0.0 |
0.1 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.2 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.3 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.0 |
0.3 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 |
0.2 |
GO:0050710 |
negative regulation of cytokine secretion(GO:0050710) |
| 0.0 |
0.3 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 |
0.0 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 |
0.0 |
GO:0006848 |
pyruvate transport(GO:0006848) mitochondrial pyruvate transport(GO:0006850) pyruvate transmembrane transport(GO:1901475) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.0 |
0.0 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.1 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 |
0.1 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
2.0 |
GO:0038096 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 |
0.1 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.3 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.1 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.0 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
| 0.0 |
0.0 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.0 |
0.2 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.1 |
GO:0030260 |
entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.0 |
0.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.1 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 |
0.0 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.3 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.0 |
GO:0002763 |
positive regulation of myeloid leukocyte differentiation(GO:0002763) |
| 0.0 |
0.0 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
0.1 |
GO:0014010 |
regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
| 0.0 |
0.1 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.3 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.0 |
0.0 |
GO:2001212 |
regulation of vasculogenesis(GO:2001212) |
| 0.0 |
0.0 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.0 |
0.0 |
GO:0031644 |
regulation of neurological system process(GO:0031644) |
| 0.0 |
0.2 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.0 |
0.1 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.0 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.0 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.0 |
0.0 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.0 |
0.1 |
GO:2001235 |
positive regulation of apoptotic signaling pathway(GO:2001235) |
| 0.0 |
0.0 |
GO:0008306 |
associative learning(GO:0008306) |
| 0.0 |
0.0 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.0 |
0.0 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
| 0.0 |
0.1 |
GO:1902035 |
regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.1 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.0 |
0.0 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.0 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.0 |
0.1 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.0 |
0.0 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.2 |
GO:0006417 |
regulation of translation(GO:0006417) |
| 0.0 |
0.0 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.0 |
0.0 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.0 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.0 |
0.2 |
GO:0033233 |
regulation of protein sumoylation(GO:0033233) |
| 0.0 |
0.1 |
GO:0099587 |
iron ion transmembrane transport(GO:0034755) inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
| 0.0 |
0.1 |
GO:0010713 |
negative regulation of collagen metabolic process(GO:0010713) |
| 0.0 |
0.0 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.0 |
0.0 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.0 |
0.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.0 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.0 |
0.0 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 |
0.0 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.1 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.2 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.1 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.0 |
GO:0098969 |
neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 0.0 |
0.0 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.1 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.0 |
1.0 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 |
0.8 |
GO:0030216 |
keratinocyte differentiation(GO:0030216) |
| 0.0 |
0.0 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.0 |
GO:0032434 |
regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
| 0.0 |
0.1 |
GO:0019226 |
transmission of nerve impulse(GO:0019226) |
| 0.0 |
0.0 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
